Stocks
Allogene Therapeutics (ALLO) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -19.7% | -51.0% | -63.9% | -61.0% | -65.3% | -62.3% | ||
| Changes by years, y/y, % | +3pp | -31pp | -13pp | +3pp | -4pp | +23.0% | |||
Allogene Therapeutics. ROE, %
Allogene Therapeutics. ROE, changes, pp
Allogene Therapeutics (ALLO) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -65.5% | -68.8% | -67.2% | -65.3% | -62.3% | -62.3% | |
| Changes by years, y/y, % | -1pp | -14pp | -5pp | -4pp | +3pp | |||
| Changes by quarters, q/q, % | -4pp | -3pp | +2pp | +2pp | +3pp | |||
